selected scholarly activity
-
chapters
-
conferences
- MUSCLE-FIBER CONDUCTION-VELOCITY COMPUTATION - DIP ANALYSIS TECHNIQUE VERSUS CROSS-CORRELATION TECHNIQUES. Muscle and Nerve. 873-873. 1990
- Muscarinic receptors in circular smooth muscle/deep muscular plexus of dog ileum. European Journal of Pharmacology. 2192-2192. 1990
- DIFFERENTIAL LABELING OF PRESYNAPTIC AND POSTJUNCTIONAL MUSCARINIC RECEPTORS BY H-3-N-METHYLSCOPOLAMINE (NMS) IN DOG ILEUM. Trends in Pharmacological Sciences. 108-109. 1989
- AGE-RELATED-CHANGES IN GABA RECEPTORS. Neuroendocrinology Letters. 157-157. 1985
- EFFECTS OF THE PINEAL AND BRAIN MONOAMINES ON ENDOCRINE FUNCTION. Neuroendocrinology Letters. 149-149. 1985
- Melatonin inhibits adenylate cyclase activity in the rat brain, pineal and retina. Journal of Steroid Biochemistry and Molecular Biology. 1461-1461. 1984
- LOCALIZATION AND CHARACTERIZATION OF MELATONIN RECEPTORS IN CNS CYTOSOL. The FASEB Journal. 1008-1008. 1980
- EFFECTS OF SEROTONIN ON ADRENOCORTICAL FUNCTION. Clinical Research. A661-A661. 1976
-
journal articles
- 5-Azacytidine upregulates melatonin MT1 receptor expression in rat C6 glioma cells: oncostatic implications. Molecular Biology Reports. 47:4867-4873. 2020
- Epigenetic regulation of melatonin receptors in neuropsychiatric disorders. British Journal of Pharmacology. 175:3209-3219. 2018
- Epigenetic induction of melatonin MT 1 receptors by valproate: Neurotherapeutic implications. European Neuropsychopharmacology. 27:828-832. 2017
- Bilateral upregulation of α-synuclein expression in the mouse substantia nigra by intracranial rotenone treatment. Experimental and Toxicologic Pathology. 69:109-114. 2017
- Altered melatonin MT 1 receptor expression in the ventral midbrain following 6-hydroxydopamine lesions in the rat medial forebrain bundle. Brain Research. 1652:89-96. 2016
- Chronic low-dose melatonin treatment maintains nigrostriatal integrity in an intrastriatal rotenone model of Parkinson’s disease. Brain Research. 1633:115-125. 2016
- Epigenetic mechanisms of melatonin action in human SH-SY5Y neuroblastoma cells. Molecular and Cellular Endocrinology. 402:57-63. 2015
- Induction of Neurotrophic and Differentiation Factors in Neural Stem Cells by Valproic Acid. Basic and Clinical Pharmacology and Toxicology. 115:216-221. 2014
- Regional upregulation of hippocampal melatonin MT2 receptors by valproic acid: Therapeutic implications for Alzheimer's disease. Neuroscience Letters. 576:84-87. 2014
- Neuroprotection by valproic acid in an intrastriatal rotenone model of Parkinson’s disease. Neuroscience. 267:114-121. 2014
- Inosine to Increase Serum and Cerebrospinal Fluid Urate in Parkinson Disease. JAMA Neurology. 71:141-141. 2014
- Melatonin induces histone hyperacetylation in the rat brain. Neuroscience Letters. 541:49-53. 2013
- Resistin expression in human granulosa cells. Endocrine. 42:742-745. 2012
- Valproic acid up-regulates melatonin MT1 and MT2 receptors and neurotrophic factors CDNF and MANF in the rat brain. International Journal of Neuropsychopharmacology. 15:1343-1350. 2012
- HDAC inhibitor M344 suppresses MCF-7 breast cancer cell proliferation. Biomedicine and Pharmacotherapy. 66:232-236. 2012
- 2-[125I]Iodomelatonin binding sites in hamster and chick exhibit differential sensitivity to prazosin. Journal of Pharmacy and Pharmacology. 41:356-357. 2011
- Epigenetic targets for melatonin: induction of histone H3 hyperacetylation and gene expression in C17.2 neural stem cells. Journal of Pineal Research. 45:277-284. 2008
- Clinically relevant concentrations of valproic acid modulate melatonin MT1 receptor, HDAC and MeCP2 mRNA expression in C6 glioma cells. European Journal of Pharmacology. 589:45-48. 2008
- Neural stem cell transplantation and melatonin treatment in a 6‐hydroxydopamine model of Parkinson’s disease. Journal of Pineal Research. 43:245-254. 2007
- Modulation of tyrosine hydroxylase expression by melatonin in human SH-SY5Y neuroblastoma cells. Neuroscience Letters. 419:202-206. 2007
- Human melatonin MT1 receptor induction by valproic acid and its effects in combination with melatonin on MCF-7 breast cancer cell proliferation. European Journal of Pharmacology. 560:17-22. 2007
- Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease. Brain Research. 1068:230-236. 2006
- Novel targets for valproic acid: up‐regulation of melatonin receptors and neurotrophic factors in C6 glioma cells. Journal of Neurochemistry. 95:1227-1236. 2005
- Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers.. BMC Neuroscience. 5:41-41. 2004
- Modulation of Dopaminergic Activity in the Striatum by Benzodiazepines and Melatonin. Pharmacology Communications. 12:171-178. 2002
- Induction of GDNF mRNA expression by melatonin in rat C6 glioma cells. NeuroReport. 13:473-475. 2002
- Analog binding to melatonin receptors in chick brain: Effects of GTP and prazosin. Medicinal Chemistry Research. 10:114-121. 2000
- Agonistic action of 2-phenylmelatonin on adenylyl cyclase activity in the rat hypothalamus. Pharmacology Reviews and Communications. 10:305-309. 1999
- Diazepam Inhibits Forskolin‐Stimulated Adenylyl Cyclase Activity in Human Tumour Cells. Basic and Clinical Pharmacology and Toxicology. 85:153-156. 1999
- Melatonin receptor mRNA expression in human granulosa cells. Molecular and Cellular Endocrinology. 156:107-110. 1999
- Mechanisms underlying the antidopaminergic effect of clonazepam and melatonin in striatum. Neuropharmacology. 36:1659-1663. 1997
- Sensitization of G Protein‐Coupled Benzodiazepine Receptors in the Striatum of 6‐Hydroxydopamine‐Lesioned Rats. Journal of Neurochemistry. 69:1920-1926. 1997
- A marked diurnal rhythm of melatonin ML1A receptor mRNA expression in the suprachiasmatic nucleus. Brain Research. 49:303-306. 1997
- Modulation of c-fos expression in the rat striatum by diazepam. Neuroscience Letters. 236:5-8. 1997
- The antidopaminergic action of S-20098 is mediated by benzodiazepine/GABAA receptors in the striatum. Brain Research. 756:293-296. 1997
- PK 11195 blockade of benzodiazepine‐induced inhibition of forskolin‐stimulated adenylate cyclase activity in the striatum. British Journal of Pharmacology. 119:223-228. 1996
- Benzodiazepine-induced inhibition of human malignant melanoma (M-6) cell growth.. Anticancer Research. 16:1259-1263. 1996
- Central-type benzodiazepine receptors mediate the antidopaminergic effect of clonazepam and melatonin in 6-hydroxydopamine lesioned rats: involvement of a GABAergic mechanism.. Journal of Pharmacology and Experimental Therapeutics. 274:84-89. 1995
- Melatonin receptors on human granulosa cell membranes. Journal of Clinical Endocrinology and Metabolism (JCEM). 80:1747-1749. 1995
- Melatonin receptors on human granulosa cell membranes.. Journal of Clinical Endocrinology and Metabolism (JCEM). 80:1747-1749. 1995
- Heparin Inhibits Melatonin Binding and Signal Transduction in Chick Brain. NeuroSignals. 3:26-33. 1994
- Physiological regulation of melatonin receptors in rat suprachiasmatic nuclei: diurnal rhythmicity and effects of stress. Molecular and Cellular Endocrinology. 98:43-48. 1993
- Human malignant melanoma cells express high-affinity receptors for melatonin: antiproliferative effects of melatonin and 6-chloromelatonin. European Journal of Pharmacology. 246:89-96. 1993
- Diurnal variation and binding characteristics of melatonin in the mouse brain and gastrointestinal tissues. Comparative Biochemistry and Physiology, Part C. 104:221-224. 1993
- Muscle fiber conduction velocity and mean power spectrum frequency in neuromuscular disorders and in fatigue. Muscle and Nerve. 15:780-787. 1992
- Involvement of multiple sulfhydryl groups in melatonin signal transduction in chick brain. Molecular and Cellular Endocrinology. 85:53-63. 1992
- Expression of nanomolar-affinity binding sites for melatonin in Syrian hamster RPMI 1846 melanoma cells. Cellular Signalling. 4:201-207. 1992
- Improved techniques for measuring muscle fiber conduction velocity. Muscle and Nerve. 15:410-418. 1992
- Muscle fiber conduction velocity: dip analysis versus cross correlation techniques.. Clinical Neurophysiology. 31:473-482. 1991
- Pertussis toxin blocks melatonin-induced inhibition of forskolin-stimulated adenylate cyclase activity in the chick brain. Biochemical and Biophysical Research Communications. 178:786-792. 1991
- 3‐[(3‐Cholamidopropyl)dimethylammonio]‐1‐Propane Sulfonate‐Solubilized Binding Sites for 2‐[125I]Iodomelatonin in Chick Brain Retain Sensitivity to Guanine Nucleotides. Journal of Neurochemistry. 56:580-586. 1991
- A novel and sensitive radioreceptor assay for serum melatonin levels. Life Sciences. 49:1895-1900. 1991
- Melatonin Interaction with the Benzodiazepine-GABA Receptor Complex in the CNS. Advances in Experimental Medicine and Biology. 294:267-277. 1991
- Pharmacological inhibition of forskolin-stimulated adenylate cyclase activity in rat brain by melatonin, its analogs, and diazepam. Biochemical Pharmacology. 40:2701-2705. 1990
- Picomolar-affinity binding and inhibition of adenylate cyclase activity by melatonin in syrian hamster hypothalamus. Cellular and Molecular Neurobiology. 10:553-558. 1990
- GTP modulates [125I]iodomelatonin binding to a picomolar-affinity site in the Syrian hamster hypothalamus. European Journal of Pharmacology. 189:95-98. 1990
- Allosteric modulation of t-[35S]butylbicyclophosphorothionate binding in rat brain by melatonin. Brain Research Bulletin. 24:635-638. 1990
- MOLECULAR MASS OF THE MELATONIN RECEPTOR IN HAMSTER HYPOTHALAMUS AND CHICKEN RETINA. Neuroscience Research Communications. 6:11-18. 1990
- On the parameterization of the EMG interference pattern power spectrum (EMG-IP-PS). Clinical Neurophysiology. 30:213-225. 1990
- Pharmacological characterization of melatonin binding sites in Syrian hamster hypothalamus. European Journal of Pharmacology. 175:71-77. 1990
- Identification and characterization of presynaptic and postsynaptic beta adrenoreceptors in the longitudinal smooth muscle/myenteric plexus of dog ileum.. Journal of Pharmacology and Experimental Therapeutics. 251:305-310. 1989
- 2-[I-125] IODOMELATONIN BINDING-SITES IN HAMSTER AND CHICK EXHIBIT DIFFERENTIAL SENSITIVITY TO PRAZOSIN. Journal of Pharmacy and Pharmacology. 41:356-357. 1989
- EMG interference pattern power spectrum analysis in neuro-muscular disorders.. Clinical Neurophysiology. 29:473-484. 1989
- High-affinity binding sites for melatonin in hamster spleen. Medical Science Research. 17:179-180. 1989
- Melatonin enhancement of [3H]-γ-aminobutyric acid and [3H]muscimol binding in rat brain. Biochemical Pharmacology. 37:1271-1274. 1988
- Age-related changes in GABA and benzodiazepine receptor binding in rat brain are influenced by sampling time. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 12:337-344. 1988
- HPLC-purified 2-[125I]iodomelatonin labels multiple binding sites in hamster brain. Biochemical and Biophysical Research Communications. 147:949-956. 1987
- Effects of chronic melatonin administration on GABA and diazepam binding in rat brain. Journal of Neural Transmission. 70:117-124. 1987
- [3H] Melatonin Binding in Membrane and Cytosol Fractions From Rat and Calf Brain. Journal of Pineal Research. 4:89-98. 1987
- Effects of P-chlorophenylalanine on pineal and endocrine function in the rat. Pharmacological Research Communications. 16:851-864. 1984
- In vitro effects of melatonin on [3H]muscimol binding in rat brain. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 8:669-672. 1984
- N-Acetylserotonin in the central nervous system. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 8:475-480. 1984
- Characteristics of high affinity binding of [3H]N-acetylserotonin in rat brain. Neuropharmacology. 22:1311-1314. 1983
- Arginine vasotocin stimulates glucocorticoid secretion in male rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 7:841-844. 1983
- Effects of blinding and pinealectomy on regional brain monoamine concentrations. Journal of Neuroscience Research. 10:53-60. 1983
- A serotonergic component of [3H]N-acetylserotonin binding in mammalian brain. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 6:421-424. 1982
- Melatonin: Origin, Control of Circadian Rhythm and Site of Action. Advances in the biosciences. 29:193-196. 1981
- Physiologic Regulation of Melatonin. Advances in the biosciences. 29:95-112. 1981
- Localization and characterization of melatonin receptors in CNS cytosol. The FASEB Journal. 39:3902. 1980
- Melatonin receptors in brain. European Journal of Pharmacology. 55:219-220. 1979
- Pineal melatonin synthesis following neutralization of circulating. International Journal of Immunopharmacology. 1:213-217. 1979
- Role of the Pineal Gland in Diurnal Endocrine Secretion and Rhythm Regulation. Neuroendocrinology. 29:14-21. 1979
- Antigonadal effects of blinding in the presence of antibody against circulating melatonin. Life Sciences. 21:613-617. 1977
- Endocrine effects of the pineal gland and neutralization of circulating melatonin and N-acetylserotonin. Canadian Journal of Physiology and Pharmacology. 55:537-544. 1977
- Effects of Neutralization of Circulating Melatonin and N-acetylserotonin on Plasma Prolactin Levels. Neuroendocrinology. 23:14-22. 1977
- Effects of pineal and indoleamines on adrenocortical function. Clinical Research. 23. 1975